Guus F Rimmelzwaan (G F Rimmelzwaan, Guus Rimmelzwaan)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 41

Top Topics

Top Venues

Emerging microbes & infections

This page only lists publications with an associated author ORCID identifier.

Publications

Chittappen Kandiyil Prajeeth, Isabel Zdora, Giulietta Saletti, Julia Friese, Thomas Gerlach, Lucas Wilken, Jana Beicht, Mareike Kubinski, Christina Puff, Wolfgang Baumgärtner, Jeroen Kortekaas, Paul J Wichgers Schreur, Albert D M E Osterhaus, Guus F Rimmelzwaan
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging microbes & infections 13 (1) (2024)
Amare Aregay, Jan Slunečko, Misa Korva, Petra Bogovic, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Tatjana Avšič Županc, Imke Steffen, Franc Strle, Albert D M E Osterhaus, Guus F Rimmelzwaan
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins. NPJ vaccines 9 (1) (2024)
Amare Aregay, Jan Slunečko, Misa Korva, Petra Bogovic, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Tatjana Avšič Županc, Imke Steffen, Franc Strle, Albert D M E Osterhaus, Guus F Rimmelzwaan
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins. NPJ vaccines 9 (1) (2024)
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Amare Aregay, Albert D M E Osterhaus, Alina Tscherne, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection. Vaccines 12 (1) (2024)
Amare Aregay, Jan Slunečko, Misa Korva, Petra Bogovic, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Tatjana Avšič Županc, Imke Steffen, Franc Strle, Albert D M E Osterhaus, Guus F Rimmelzwaan
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins. NPJ vaccines 9 (1) (2024)
Lucas Wilken, Guus F Rimmelzwaan, Husni Elbahesh
The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Journal of virology 98 (8) (2024)
Lucas Wilken, Guus F Rimmelzwaan, Husni Elbahesh
The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Journal of virology 98 (8) (2024)
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Amare Aregay, Albert D M E Osterhaus, Alina Tscherne, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection. Vaccines 12 (1) (2024)
Lucas Wilken, Guus F Rimmelzwaan, Husni Elbahesh
The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Journal of virology 98 (8) (2024)
Amare Aregay, Jan Slunečko, Petra Bogovic, Misa Korva, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Imke Steffen, Franc Strle, Tatjana Avšič-Županc, Albert D M E Osterhaus, Guus F Rimmelzwaan
Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity. Emerging microbes & infections 13 (1) (2024)
Chittappen Kandiyil Prajeeth, Isabel Zdora, Giulietta Saletti, Julia Friese, Thomas Gerlach, Lucas Wilken, Jana Beicht, Mareike Kubinski, Christina Puff, Wolfgang Baumgärtner, Jeroen Kortekaas, Paul J Wichgers Schreur, Albert D M E Osterhaus, Guus F Rimmelzwaan
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging microbes & infections 13 (1) (2024)
Chittappen Kandiyil Prajeeth, Isabel Zdora, Giulietta Saletti, Julia Friese, Thomas Gerlach, Lucas Wilken, Jana Beicht, Mareike Kubinski, Christina Puff, Wolfgang Baumgärtner, Jeroen Kortekaas, Paul J Wichgers Schreur, Albert D M E Osterhaus, Guus F Rimmelzwaan
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging microbes & infections 13 (1) (2024)
Amare Aregay, Jan Slunečko, Petra Bogovic, Misa Korva, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Imke Steffen, Franc Strle, Tatjana Avšič-Županc, Albert D M E Osterhaus, Guus F Rimmelzwaan
Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity. Emerging microbes & infections 13 (1) (2024)
Lucas Wilken, Guus F Rimmelzwaan, Husni Elbahesh
The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms. Journal of virology (2024)
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Amare Aregay, Albert D M E Osterhaus, Alina Tscherne, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection. Vaccines 12 (1) (2024)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Ayse Agac, Sophie M Kolbe, Martin Ludlow, Albert D M E Osterhaus, Robert Meineke, Guus F Rimmelzwaan
Host Responses to Respiratory Syncytial Virus Infection. Viruses 15 (10) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Lucas Wilken, Sonja Stelz, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses 15 (4) (2023)
Niranjana Nair, Albert D M E Osterhaus, Guus F Rimmelzwaan, Chittappen Kandiyil Prajeeth
Rift Valley Fever Virus-Infection, Pathogenesis and Host Immune Responses. Pathogens (Basel, Switzerland) 12 (9) (2023)
Lucas Wilken, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 11 (4) (2023)
Miguel Ángel Palacios-Pedrero, Janina M Jansen, Cornelia Blume, Nils Stanislawski, Rebecca Jonczyk, Antonia Molle, Mariana Gonzalez Hernandez, Franziska Karola Kaiser, Klaus Jung, Albert D M E Osterhaus, Guus F Rimmelzwaan, Giulietta Saletti
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults. Nature aging 2 (10) (2022)
Lukas Mathias Michaely, Lukas Schuwerk, Lisa Allnoch, Kathleen Schön, Inken Waltl, Pia-Katharina Larsen, Andreas Pavlou, Chittappen Kandiyil Prajeeth, Guus F Rimmelzwaan, Stefanie C Becker, Ulrich Kalinke, Wolfgang Baumgärtner, Ingo Gerhauser
Intact Type I Interferon Receptor Signaling Prevents Hepatocellular Necrosis but Not Encephalitis in a Dose-Dependent Manner in Rift Valley Fever Virus Infected Mice. International journal of molecular sciences 23 (20) (2022)
Miguel Ángel Palacios-Pedrero, Janina M Jansen, Cornelia Blume, Nils Stanislawski, Rebecca Jonczyk, Antonia Molle, Mariana Gonzalez Hernandez, Franziska Karola Kaiser, Klaus Jung, Albert D M E Osterhaus, Guus F Rimmelzwaan, Giulietta Saletti
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults. Nature aging 2 (10) (2022)
Luca M Zaeck, Mart M Lamers, Babs E Verstrepen, Theo M Bestebroer, Martin E van Royen, Hannelore Götz, Marc C Shamier, Leanne P M van Leeuwen, Katharina S Schmitz, Kimberley Alblas, Suzanne van Efferen, Susanne Bogers, Sandra Scherbeijn, Guus F Rimmelzwaan, Eric C M van Gorp, Marion P G Koopmans, Bart L Haagmans, Corine H Geurts van Kessel, Rory D De Vries
Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nature medicine (2022)
Alexander Postel, Jacqueline King, Franziska Karola Kaiser, Johanna Kennedy, Mara Sophie Lombardo, Wencke Reineking, Madeleine de le Roi, Timm C Harder, Katja V Goller, Thomas Gerlach, Guus F Rimmelzwaan, Simon Rohner, Lotte C Striewe, Stephanie Gross, Luca Aroha Schick, Jana C Klink, Katharina Kramer, Albert D M E Osterhaus, Martin Beer, Wolfgang Baumgärtner, Ursula Siebert, Paul Becher
Infections with highly pathogenic avian influenza A virus (HPAIV) H5N8 in harbor seals at the German North Sea coast, 2021. Emerging microbes & infections 11 (1) (2022)
Miguel Ángel Palacios-Pedrero, Janina M Jansen, Cornelia Blume, Nils Stanislawski, Rebecca Jonczyk, Antonia Molle, Mariana Gonzalez Hernandez, Franziska Karola Kaiser, Klaus Jung, Albert D M E Osterhaus, Guus F Rimmelzwaan, Giulietta Saletti
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults. Nature aging 2 (10) (2022)
Miguel Ángel Palacios-Pedrero, Janina M Jansen, Cornelia Blume, Nils Stanislawski, Rebecca Jonczyk, Antonia Molle, Mariana Gonzalez Hernandez, Franziska Karola Kaiser, Klaus Jung, Albert D M E Osterhaus, Guus F Rimmelzwaan, Giulietta Saletti
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults. Nature aging 2 (10) (2022)
Miguel Ángel Palacios-Pedrero, Janina M Jansen, Cornelia Blume, Nils Stanislawski, Rebecca Jonczyk, Antonia Molle, Mariana Gonzalez Hernandez, Franziska Karola Kaiser, Klaus Jung, Albert D M E Osterhaus, Guus F Rimmelzwaan, Giulietta Saletti
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults. Nature aging 2 (10) (2022)
Miguel Ángel Palacios-Pedrero, Janina M Jansen, Cornelia Blume, Nils Stanislawski, Rebecca Jonczyk, Antonia Molle, Mariana Gonzalez Hernandez, Franziska Karola Kaiser, Klaus Jung, Albert D M E Osterhaus, Guus F Rimmelzwaan, Giulietta Saletti
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults. Nature aging 2 (10) (2022)
Robert Meineke, Sonja Stelz, Maximilian Busch, Christopher Werlein, Mark Kühnel, Danny D Jonigk, Guus F Rimmelzwaan, Husni Elbahesh
FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections. Viruses 14 (9) (2022)
Monique Petry, Martin Palus, Eva Leitzen, Johanna Gracia Mitterreiter, Bei Huang, Andrea Kröger, Georges G M G M Verjans, Wolfgang Baumgärtner, Guus F Rimmelzwaan, Daniel Ruzek, Albert Osterhaus, Chittappen Kandiyil Prajeeth
Immunity to TBEV Related Flaviviruses with Reduced Pathogenicity Protects Mice from Disease but Not from TBEV Entry into the CNS. Vaccines 9 (3) (2021)
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Asisa Volz, Gerd Sutter, Guus F Rimmelzwaan
Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise. Vaccines 8 (3) (2020)
Lucas Wilken, Guus F Rimmelzwaan
Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design? Pathogens (Basel, Switzerland) 9 (6) (2020)
Robert Meineke, Guus F Rimmelzwaan, Husni Elbahesh
Influenza Virus Infections and Cellular Kinases. Viruses 11 (2) (2019)
A F Altenburg, S E Magnusson, F Bosman, L Stertman, R D de Vries, Guus F Rimmelzwaan
Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice. Clinical and experimental immunology 190 (1) (2017)